San Francisco, United States
LatchBio, founded in 2021, has quickly carved a niche in the Biotechnology sector with its innovative slogan, "Agent Infrastructure for Biology." Headquartered in the United States, it provides integrated agent infrastructure bundled with kits and machines, effectively serving over 300 pharma, biotech, and academic teams worldwide.
In a notable show of confidence from investors, LatchBio recently secured a substantial $130.00M Series B investment on 01 April 2026. This investment highlights both the promising growth trajectory of the company and the market's strong belief in its ability to innovate and expand within a highly competitive industry.
